The frequency of selective IgA deficiency was determined in a healthy population of 6,240 blood donors. Screening for IgA deficiency was performed by double-diffusion analysis in agarose gel. Confirmation testing was performed with the more sensitive passive hemagglutination inhibition assay. Prevalence of IgA deficiency, characterized by a serum level of below 50 irig/L, was 0.30% (1 in 328) , which is the highest prevalence of selective IgA deficiency reported in a healthy population. Antibodies to IgA were detected in sera of 36.8% of the blood donors with selective IgA deficiency, which also is the highest prevalence of anti-IgA antibodies reported in any previous study.
The literature on IgA deficiency in healthy populations is reviewed. Current concepts in treatment of IgA-deficient patients requiring blood products are described. (Key words: Selective IgA deficiency; Blood donors) Am J Clin Pathol 1983; 80: 210-213 SELECTIVE IGA DEFICIENCY is the most commonly recognized immunodeficiency and is characterized by a serum level of <50 mg/L. 1 Selective IgA deficiency in healthy populations was recognized first in 1964.
24 Surveys of hospital patients, communities, and blood donors yield different estimates of prevalence ranging from 0.03% (1 in 3,333) to 0.31% (1 in 323).
2 ' 4 -69 -" 13 - 15 ' 7 --21, 26, 30 T n e w ft e range of prevalence is reflected in the variety of populations studied (Table 1) . Selective IgA deficiency may occur in association with recurrent sinopulmonary infections, gastrointestinal disturbances, autoimmune and allergic diseases, as well as more specific disorders, i.e., ataxia telangiectasia.
112 A predisposition to IgA deficiency is thought to be inherited by polygenic factors in most cases. 8 Numerous autoantibodies have been described in sera of subjects having selective IgA deficiency. 1, 31 The antibody of greatest clinical significance, however, appears to be an alloantibody to human IgA. Severe anaphylactic reactions may occur in IgA-deficient patients having these alloantibodies on exposure to human I g A 3, 18, 19, 23, 25, 27, 32 A f a t a j c a s e h a s b e e n r e p o r ted. 2 3 This study was undertaken to determine the preva-lence of selective IgA deficiency and the frequency of anti-IgA antibodies in sera of deficient subjects. The present study also provides a rare donor file of subjects with IgA deficiencies who can provide blood products to IgA-deficient patients who have experienced anaphylactic reactions on exposure to human IgA.
Materials and Methods
Aliquots of serum samples from 6,240 blood donors collected for routine donor processing were obtained for this study. Sera were stored between 22°C and 24°C for less than 48 hours. The sera were screened for IgA deficiency by double-diffusion analysis in agarose gel. Ouchterlony's microtechnique gel diffusion (Meloy Laboratories, Springfield, VA) with rosettes of five peripheral wells (for serum samples) and one central well (for the IgA antisera) was the test method. The Ouchterlony plates contained 1.5% agarose dissolved in phosphate buffer, pi\ 8. Antisera was commercial goat anti-IgA, a chain specific (Meloy Laboratories, Springfield, VA); each lot of antisera was tested against both normal and known IgA-deficient control sera. The plates were incubated overnight at room temperature and then examined grossly for precipitation lines. Sensitivity of the assay was 50 mg/L. Serum samples negative for IgA by Ouchterlony immunodiffusion were sent to the National American Red Cross Immunohematology Laboratory for confirmation by a hemagglutination inhibition method.
29 Sensitivity of this assay was 1.0 mg/L. Serum values were reported as either less than or greater than 1.0 mg/L.
Presence of limited or class specific anti-IgA antibodies in IgA-deficient donor sera was determined by the National American Red Cross Immunohematology Laboratory. 1 Sera from 19 blood donors were negative by Ouchterlony immunodiffusion and therefore were IgA deficient. Prevalence of IgA deficiency in the blood donor population studied was 0.30% (one in 328; Table 1 ). Fifteen of the 19 IgA deficient blood donors had serum IgA levels of less than 1.0 mg/L by hemagglutination inhibition assay. The remaining four IgA-deficient blood donors had greater than 1.0 mg/L serum IgA by hemagglutination inhibition assay and were designated "low level" ( Table 2) .
Seven of the 19 (36.8%) blood donors deficient in IgA had antibodies to IgA ( Table 3 ). Six of these seven IgAdeficient blood donors possessed class-specific antibodies. The remaining donor possessed an antibody of limited specificity. Three of these seven anti-IgA antibodies were high titered (> 1:256) and class specific ( Table 2 ). Table 3 compares the incidence and specificity of antiIgA antibodies in this study with that in previous reports.
Discussion
A survey of 6,240 blood donors revealed 19 subjects with a deficiency of IgA (Table 2) . Fifteen subjects had IgA values of less than 1.0 mg/L. Four additional subjects had IgA values between 1.0 mg/L and 50 mg/L. The prevalence of selective IgA-deficient subjects is 0.30% (1 in 328), which is the highest prevalence ever reported in a healthy population (Table 1) . Previous surveys of healthy populations yield a range of prevalences from 0.03% to o.25%. 2, [4] [5] [6] IU4, 15, 17, 21, 26, 30 Surveys of hospitalized patients yield prevalences ranging from 0.17 to 0.31%. 9, 10, 13 The reason for the high prevalence of selective IgA deficiency in this study is unknown. Prevalence of IgA deficiency appears to be regional. One investigator suggests that less mobile populations may have increased prevalence because of distant consanguinity 6 ; this hypothesis may apply to this study. The age and sex of deficient subjects in this study were consistent with the normal blood donor population.
Anti-IgA antibodies often are present in sera of healthy individuals who have IgA deficiencies and no history of prior sensitization. 1, 4, 29 Antibodies to IgA are found more frequently in sera of patients with selective IgA deficiency who present with clinical disease. Anti-IgA antibodies are class specific (react to all IgA proteins) or of limited specificity (react with some but not all IgA proteins).
29 Anti-IgA antibodies were found in sera of seven of nineteen (36.8%) IgA-deficient blood donors, a prevalence rate higher than described in other studies of apparently healthy donors (Table 3) . ' 1,16,17,26.30 Six donor sera exhibited class specific antibodies; one donor serum had antibodies of limited specificity. AntiIgA is an IgG antibody and is capable of fixing complement. Plasma containing IgA given to deficient sub- 29 Three of the six class-specific antibodies in this study have high titers (Table 2 ). Blood with antiIgA antibodies in plasma administered to normal patients leads to no untoward effects apparently because of dilution of antibody in the recipient. 26, 30 The selective IgA-deficient patients with serum antiIgA must receive blood products lacking IgA to avoid possibly fatal anaphylactic reactions. Selective IgA-deficient patients who do not have serum anti-IgA antibodies probably should receive blood products lacking IgA to avoid sensitization. Three ways to accomplish this task exist. Autologous blood may be stored for administration if the need for blood can be anticipated. This method is the safest means of providing blood products to patients with selective IgA deficiency. Also, administration of thoroughly washed 18, 27 or frozen-thawedwashed cells 19 has been suggested as a safe method of transfusing IgA-deficient patients. IgA-deficient patients have been reported to react to both of these products, however.
1819 The IgA concentration in the supernatant fluid of frozen-thawed-washed cells is significantly less than concentrations in the supernatant fluid of routinely washed cells. 33 Further washing of frozen cells with saline reduces IgA concentrations in supernatant fluids below the radioimmunoassay detection limit. 33 Thoroughly washed preparations of frozen-thawed-washed red blood cells result in quantities of IgA in supernatant fluids equal to or less than IgA-deficient red blood cell products. 33 The risk of transfusing red blood cells prepared in this manner is minimal. The third means of providing blood products to patients with selective IgA deficiency is achieved by obtaining IgA-deficient products through a rare donor file. The American Red Cross Rare Donor Registry and the American Association of Blood Banks Rare Donor File provide rapid access to IgA-deficient products. These files are available for national use, regardless of organizational affiliation.
This study has resulted in identification of 15 selective IgA-deficient subjects who should provide safe (<1.0 mg/L IgA) blood products for patients with selective IgA deficiency. Availability of these products is essential for the selective IgA deficient patient who requires plasma infusion and has class-specific antibodies. Two calcium alginate-tipped wire swab specimens were obtained from 94 men and 106 women attending a sexually transmitted disease clinic. One swab was extracted thoroughly in 2-sucrose phosphate (2SP) immediately after obtaining the specimen. The second swab was returned to the Culturette® cylinder (Marion Scientific, Kansas City, MO), and the ampule containing 2SP was crushed to moisten the swab during transport to the laboratory. After receipt in the laboratory, the swab was removed from the Culturette and extracted into 2 mL of 2SP. Both specimens then were cultured for the presence of Chlamydia trachomatis in McCoy's cells. C. trachomatis was recovered from 22 of 94 men (23.4%); 16 isolates came from both the Culturette swabs and vials. Six isolates were recovered exclusively from vials. Of 106 women, 13 (12.3%) were positive for C. trachomatis. In five instances, both vials and swabs yielded C. trachomatis; the organism was recovered eight times from vials but not swabs. The 2SP transport system for the 200 specimens was superior to the Culturettes for the recovery of C. trachomatis (P < 0.01). Based on our results, swab specimens taken for laboratory diagnosis of C. trachomatis should be extracted immediately after collection in a vial containing 2SP. In addition, experiments comparing swab fibers indicated that there was a trend indicating higher inclusion counts with rayon-tipped swabs, compared with those containing calcium alginate. Because of possible toxicity of substances in calcium alginate fibers for several organisms causing sexually transmitted disease, rayontipped swabs or swabs of other composition should be used. 
CHLAMYDIA TRACHOMATIS
has emerged as the most common cause of sexually transmitted disease. 58, 9 In addition to uncomplicated urethritis and cervicitis, * Deceased January 25, 1983 . Received October 14, 1982 ; received revised manuscript and accepted for publication January 26, 1983. Address reprint requests to Dr. this agent has been implicated as a cause of epididymitis in men and a number of systemic infections in women, which include pelvic inflammatory disease (salpingitis, Fitz-Hugh-Curtis syndrome, endometritis), and pneumonia in infants and adults. 3 C. trachomatis and Neisseria gonorrhoeae are strikingly similar in the disease manifestations that they cause, yet they differ from one another in their susceptibility to many antibiotics. 9 Importantly, these two agents are found as mixed infections with a frequency of about 30%. 4 Thus, there is a pressing need to be able to provide diagnostic services for the detection of C. trachomatis as well as other agents in order to institute the most effective antimicrobial therapy. Efficient recovery of C. trachomatis depends on the extraction of swabs in 2-sucrose phosphate (2SP) medium before their transport to the laboratory. Usually, the laboratory is called upon to supply and distribute the 2SP transport medium to the clinical facilities. Our goal was to determine if commercially prepared swabs tipped with calcium alginate transported in "Culturettes"® (ampule containing 2SP rather than Stuart's transport medium-Marion Scientific, Kansas City, MO) could replace the requirement for supply of 2SP transport medium in glass vials for the recovery of C. trachomatis.
Materials and Methods
Calcium alginate swabs were prepared by Marion Scientific, Kansas City, Missouri. Each swab was inserted 
